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1 
Introduction to the DNP Practice Inquiry Project  
In 1967 Dame Cicely Saunders opened the first hospice in London pioneering the 
theories and practice of pain control in the dying patient.1 Since then, the modern hospice and 
palliative care movement has flourished worldwide. The delivery of palliative care is achieved 
through an interdisciplinary approach to treat the physical, psychosocial and spiritual dimensions 
of patients and families living with a serious illness. Palliative care can occur at any stage in the 
disease trajectory, from the point of diagnosis up until the end of life. The Clinical Nurse 
Specialist (CNS) is uniquely prepared to reshape existing paradigms for health care delivery and 
contribute meaningfully to the expansion of the specialty of hospice and palliative care. This 
practice inquiry project applies the CNS conceptual model describing the three spheres of 
influence to the hospice and palliative care practice setting.  
The conceptual model for CNS practice describes three spheres of influence: the 
patient/family, nurses and nursing practice, and organizations/systems. In the 50 years since the 
development of the specialty, the role of the CNS has evolved to address the changing needs of 
patients along the healthcare continuum, systems delivery models, educational preparations, and 
the scientific and theoretical underpinnings of outcomes based nursing practice.2 National 
Association of Clinical Nurse Specialists states the CNS prepared at the doctoral level will be 
equipped with additional skills and competencies to advance healthcare and the nursing 
profession through the evaluation and translation of evidence based practice, utilization of 
theories and models from a variety of disciplines, improvement of quality of care and safety, and 
providing the kind of leadership which fosters the interprofessional communication necessary to 
make these transformational changes.3   
2 
The following describes the DNP project I implemented and the synthesis of my program 
of inquiry to fulfil the DNP degree requirements at the University of Kentucky. The first 
manuscript focuses on the organizations/systems sphere of influence and is an integrative review 
of the literature describing current practice and recommended standards for the care of patients 
with implantable cardioverter defibrillators at the end of life in adults. The second manuscript 
focuses on nurses, the nursing profession and the patient/family sphere. This manuscript 
describes the adoption of an evidence-based bowel protocol for standing orders in a home 
hospice environment utilizing the chronic care model as a framework. The final manuscript 
focuses on the patient/family sphere and describes a study to assess perceptions of palliative care 
among patients with serious illness in the acute setting utilizing a video enhanced educational 
intervention.  
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Abstract 
Background: Active implantable cardioverter defibrillators (ICDs) have the potential to 
decrease quality of life patients with terminal cardiac diagnosis at the end of life. The informed 
consent process prior to device placement should include both short and long term goals as well 
as consequences of ICD implantation. Often, these ramifications may not be consistently 
discussed or understood by patients. The purpose of this paper is to conduct an integrative review 
of the literature to examine the knowledge, attitudes, and perceptions of ICD deactivation and 
end of life issues among ICD recipients. Methods: PubMed was searched using the key words 1) 
“implantable cardioverter defibrillator” AND “end of life” AND “adult”. Eligible studies were 
published within the last five years, written in English, and were specific to patient attitudes, 
knowledge and perceptions of ICD deactivation at the end of life. Result: Patients are likely to 
have insufficient knowledge regarding ICD deactivation, and a minority of them recall receiving 
information about deactivation from their healthcare provider prior to implantation. Patients with 
ICDs are less likely to have advance directives in place. Among those that do, these advance 
directives rarely address ICDs specifically. Discussion: Although the literature suggests rate 
discussions with their health care providers regarding ICD deactivation as important, they 
continue to demonstrate unrealistic expectations regarding the life prolonging potential of ICDs 
when considering decision making at end of life. Conclusion:  The rigorous nature of ICD 
monitoring provides many opportunities to increase the amount of patients with advanced 
directives and is consistent with expert recommendations by both the Heart Rhythm Society and 
the European Heart Rhythm Society.  
 
Key words: implantable cardioverter-defibrillator, end of life care, palliative care  
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Knowledge and Perceptions of Implantable Cardioverter Defibrillator Deactivation at the End of 
Life in Adults: An Integrative Review  
Implantable cardioverter defibrillator therapy (ICD) is indicated for primary and 
secondary prevention of sudden cardiac death with measures of left ventricular ejection fraction 
used to guide appropriateness of therapy. 1 For patients at risk of sudden cardiac death due to 
ventricular arrhythmias, ICDs can monitor heart rhythm and provide pacing or defibrillation as 
needed. 2 The American Heart Association 3 estimates that approximately 10,000 individuals are 
implanted with an ICD each month. Despite these interventions, patients who avoid sudden 
cardiac death will likely succumb to progressive worsening of underlying heart failure 4 or the 
development of other progressive life-limiting illnesses. In 2010, approximately one in nine 
death certificates (about 279,098 deaths) mentioned heart failure. Of these, about 57,757 were 
directly attributable to heart failure. 5  
Patients have unrealistic expectations of the ICD’s ability to prevent cardiac related 
deaths, particularly those with a diagnosis of heart failure. 6 Extension of ICD therapy into the 
end of life can have significant negative psychosocial and physical consequences for patients, 
leading to diminished quality of death. 7,8 The progressive nature of terminal illnesses can 
increase the likelihood of arrhythmia inducing conditions such as pain, electrolyte abnormalities, 
hypoxia, sepsis, and worsening heart failure leading to an increased frequency of ICD shocks. 9 
Episodes of shock can cause significant physical pain as well as psychological distress for the 
recipient. 9 A survey of 900 hospice programs in the United States revealed that 97% had 
admitted at least one patient with an ICD in the preceding year, with 58% of those reporting a 
patient had received a shock during that time. 10 Device deactivation occurs late in the disease 
course and is often prompted by acute hospitalizations with a majority of patients having their 
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ICD deactivated in the last week of life. 11 There are legitimate concerns regarding the economic 
consequences of prolonged aggressive therapies. The AHA reports that the total direct and 
indirect costs of cardiovascular disease and stroke in the United States exceed $503 billion, 
making these disease groups the number one driver of healthcare costs among any other 
diagnostic group. 12 
Purpose 
The Institute of Medicine 13 report “Crossing the Quality Chasm: A New System for the 
21st Century” mandates models of care which are patient-centered to achieve optimum quality 
outcomes. According to this report, patient-centeredness occurs when providers collaborate with 
patients to design plans of care which are in line with their needs, desires and level of 
understanding. Consensus statements by the European Heart Rhythm Society 9 and the Heart 
Rhythm Society 14 affirm that ICD deactivation is both ethically and legally permissible at the 
end of life. These statements also reiterate the IOM mandate of patient-centered care delivery, 
recommending that ongoing discussion regarding any cardiovascular implantable electronic 
devices should begin prior to initiation of these therapies. 
The existing literature suggests that provider practice and attitudes regarding end of life 
issues for patients receiving ICD therapy may be mismatched. Notably, this phenomena has been 
investigated during the informed consent process among electrophysiologists. 15,16 When asked, 
physician providers have acknowledged the importance of discussing end of life issues with 
patients15,17,18; however, examinations of medical records do not reflect this intention. 16 To 
effectively translate the Heart Rhythm Society and European Heart Rhythm Society 
recommendations into practice both sides of the patient-provider transaction must be understood 
in order to identify opportunities with the highest likelihood of success.  The aim of this 
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integrative review is to synthesize the literature describing the knowledge, attitudes, and 
perceptions of ICD deactivation and end of life issues among ICD recipients. 
Methods 
In February 2014 PubMed was searched using the key words 1) “implantable cardioverter 
defibrillator” AND “end of life” AND “adult” and 2) “implantable cardioverter defibrillator” 
AND “end of life” AND “deactivation.” From these searches 133 articles were retrieved. After 
first-stage screening of titles and abstracts 25 of these articles contained all of the search 
qualifiers and were published within the last five years, and written in English.  Next, second-
stage screening was performed by reviewing the full text of the remaining articles. Excluded 
articles included four studies of provider attitudes and practice regarding ICDs at end of life, five 
case studies or expert recommendations and seven studies not specific to patient knowledge or 
attitudes regarding ICD deactivation. Nine remaining articles were included in the final review 
examining end of life issues in adult patients with ICDs (Figure 1.) 
Results 
 Seven of the studies selected for data extraction utilized retrospective cross-sectional 
correlational designs and two of the selected studies utilized qualitative methodologies (Table 1). 
The two qualitative studies reviewed both involved patient interviews with a particular focus on 
what patients recall of their pre-implantation conversations with their physicians regarding end 
of life decision making or device deactivation. The retrospective cohort studies were able to 
gather more specific data regarding quantifiable knowledge or attitudes pertaining to ICDs. Data 
extraction from all of the selected studies revealed three phenomena of interest. First, a snapshot 
emerged of patients’ current attitudes about end of life decision making specific to their ICDs. 
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Second, a substantial amount of data regarding patient knowledge of their expectations, general 
knowledge and ethical concerns emerged. Finally, data arose concerning a mismatch in patient-
provider communication.  
Current Attitudes  
In the qualitative studies reviewed, patients described an awareness of the uncertainty 
their diagnoses held for the future. Additionally they were able to describe some of their fears 
surrounding the progression of their illness, 19 and reported a desire for quality of life over 
quantity. 20 Patients tended towards optimism, focusing on the present and placing great 
confidence in the ICD’s ability to prevent sudden cardiac death, without giving much 
consideration to the potential for death due to other causes such as progressive comorbid illness 
or the development of other life-limiting illness such as cancer.  
Among the remaining seven studies, between 45.9% 21 and 86% 22 of patients reported 
that they had not previously considered ICD deactivation at end of life. A telephone survey 
conducted by Kirkpatrick and colleagues 22 found that among the minority of patients who had 
considered this, 82% of them had not discussed their concerns with a healthcare provider. The 
authors also reported that among the cohort of 278 patients who were interviewed in the 
Kirkpatrick study, 62 (22%) believed the ICD should remain activated in the event of a do not 
resuscitate order, 90 (32%) believed it should remain activated if the patient enters hospice, and 
54 (20%) were uncertain. 22  
 Herman and colleagues 21 examined how patients’ prior experiences with ICD shocks 
may affect their attitudes towards deactivation at end of life. In a sample of 112 participants from 
an outpatient setting, 31 had received a shock after implantation of their ICD. The participants in 
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this group was correlated with an increased likelihood of hospitalization compared to those who 
had not received prior shocks (1.21 vs 0.79 hospitalizations, p<0.05). Participants with prior 
shock experiences indicated this had an adverse effect on their psychological status. This group 
also felt they were insufficiently informed about the ICD compared to those with no prior shock 
experience (r=-0.368, p<0.05). Cohabitation also seemed to play a role in patient attitudes 
regarding their ICD. Patients who lived alone were more likely to report their willingness to 
deactivate their device at end of life compared to those who did not live alone (r = -0.21, p 
=0.025). 21  
An alternate study conducted by Raphael and colleagues 23 examined the relationship 
between patients’ prior experiences with ICD shocks and their preferences for device 
deactivation or end of life discussions with their healthcare provider.  Among a group of 54 
individuals from an outpatient clinic in Boston, 25% of patients with prior shock were more 
likely to consider ICD deactivation compared with only 3% of patients who had no prior shock 
experience (p = 0.01). Of the 29 participants who had not received prior shocks, 24% did not 
want to discuss end of life or deactivation with their healthcare providers. No differences were 
found in New York Heart Association class, ejection fraction or time since initiation of ICD 
between groups of patients who would consider deactivation and those who would not. In the 
event of an ICD shock patients may be forced to confront a new reality with regards to their 
health and well-being. The authors note that the incidence of an ICD shock may prompt a period 
of opportunity for healthcare providers to revisit discussions about ICD therapy goals and the 
possibility of device deactivation in the future.   
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Patient Knowledge 
Patients may have unrealistic expectations of ICDs with predominantly positive attitudes 
noted towards ICD battery replacement and place great faith in the ability of ICDs to extend life. 
19 In the largest study reviewed examining patient knowledge of ICDs, Stromberg and colleagues 
24 analyzed written surveys from 3,067 ICD recipients from the Swedish ICD and Pacemaker 
Registry. The authors found 29% of the sample had insufficient knowledge regarding their ICDs. 
Within the group, men were more likely to have sufficient knowledge than women (72%, 65%; 
p<0.001) and those less than 65 years old were more likely than those 65 or older to have 
sufficient knowledge (84%, 65%; p<0.001). The authors also found that sufficient knowledge 
was more likely if the following topics were previously discussed with a physician: battery 
replacement (n = 1,250; 76% vs 68%; p<0.001); deactivation (n=420; 76% vs 71%; p<0.001); 
and illness trajectory (n=1,080; 78% vs 67%; p<0.001). 24 
These findings are reinforced by two smaller studies. The Pedersen group 25 noted that 
31% of their sample of 294 Dutch patients did not know ICD deactivation was possible. Lower 
rates were found by Raphael and colleagues, 23 who noted only 3% of their sample (n = 54) 
could remember being informed of the potential for ICD deactivation at the time of consent. 
Although 85% of this sample could remember discussing benefits of ICD therapy at the time of 
informed consent, less than half were able to recall discussing risks or side effects.  
Misinformation regarding the ethics of device activation was explored in two studies.  In 
the large national cohort study conducted by Stromberg and colleagues 24 the authors noted 28% 
(n=796) of respondents believed deactivation to be the same as euthanasia. Those in this 
category were more likely to be older (68±11 vs 65±12; p<0.001), female (31% vs 26%; 
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p<0.001), with lower education (42% ≤9 years vs 58% education >9 years; p<0.001), low quality 
of life scores (0.793 vs 0.828; p<0.001), and also had symptoms of depression (36% vs 26%; 
p<0.001) and anxiety (33% vs 25%: p<0.001). The study conducted by Kirkpatrick and 
colleagues 22 noted 26% (n=71) considered deactivation synonymous with physician assisted 
suicide, and 8% (n=23) as unsure. The authors did note a downward trend in these rates over the 
data collection period between 2009 and 2010 which may have been attributable to spikes in 
media attention towards palliative and end-of-life issues in response to U.S. health care reform. 
Patient-Provider Communication 
As alluded to earlier in this review, relatively few patients report having spoken to their 
physicians about ICD management at end of life. Among a sample of 278 participants, the 
Kirkpatrick group 22 found that 71 (26%) had a living will, seven (3%) had a healthcare power of 
attorney and 62 (22%) had both. Kirkpatrick and colleagues 22 also reported that having an 
advanced directive was significantly associated with age; they reported those with advanced 
directives had a mean age 65 years compared to a mean age of 57 years among those without 
advanced directives (p<0.0001). No other characteristics were associated with those who had 
advanced directives versus those who did not. Most striking is that among this same group only 
three (2%) participants had an advanced directive which specifically addressed their ICD. Most 
(n = 267, 96%) had never discussed ICD deactivation at the end of life with a physician. 22] 
Herman and colleagues 21 noted similar trends in their sample of 112 participants with 45.9% 
(n=50) reporting that they had not thought about ICD deactivation at the end of life and only 
7.3% (n=8) reporting prior discussions with their physician regarding ICD management at end of 
life.  
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Only one study examined demographic characteristics of patients with advanced 
directives. These patients tended to be older at the time of implantation (69 years vs 60, 
p<0.001), white (97% vs 90, p<0.02), and living local to a large center in Minnesota (14% vs 
5%, p = 0.004). 26 With regards to primary diagnosis, patients with an advanced directive in 
place were likely to have renal insufficiency (40% vs 26%, p = 0.005), COPD (32% vs 45%, 
p<0.02), cancer (36% vs 54%, p=0.02) and dementia (4% vs 1%, p=0.03) than patients who did 
not have an advanced directive in place. Even in instances where patients had an existing advanced 
directive, this did not consistently increase likelihood of deactivation. Of 44 patients who died 
during this study period, only two patients’ advanced directives specifically mentioned ICD 
management. Additionally, ICD deactivation occurred for only seven patients (16%) at the end 
of life. This finding suggests that a clear understanding of patient goals and preferences with 
respect to the management of their ICDs at the end of life is not occurring between patients and 
their healthcare providers. 
General knowledge of advanced directives was addressed in a study conducted by Habal, 
and colleagues. 27 In their sample of 41 participants from an ambulatory setting in Ontario 31 
(76%) did not know what advanced directives were. Of 19 patients with an ICD, only two (11%) 
reported discussing ICD deactivation with a physician. After patients were educated on the 
natural course of heart failure, nine (47%) stated they would like deactivation of defibrillator if 
their condition became worse, five (26%) would not want it deactivated, three (16%) were 
unsure, and two (11%) did not answer.  
Patient preferences for the timing and methods of end of life discussions were examined 
in two studies. Eighty four percent of a sample population of patients with ICDs surveyed by the 
Pedersen group 25 believed providers should inform them of the possibility for deactivation, and 
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62% of these expressed a preference to be informed orally and in writing. Roughly half (49%) of 
these patients also reported beliefs that end of life discussions should occur before ICD therapy. 
The Rapheal group 23observed a similar finding in a sample population of 54 patients with ICDs, 
with 54% of these individuals expressing a preference for end of life discussions prior to device 
implantation. In contrast the Kirkpatrick group 22 reported patient preferences for advanced 
directive discussions at ICD follow up visits (n = 95, 34%) and end of life (n = 110, 40%) versus 
at the time of device implantation (n = 44, 16%).  
Several other factors have been reported which reflect patient preferences for provider 
communication regarding provider discussions about end of life decision making specific to ICD 
management. The Pedersen group 25 observed patient preferences for these conversations when 
life expectancy is decreased (55%), before battery replacement (17%), and during the dying 
process (26%). Patients responded they preferred these conversations initiated by their 
electrophysiologists (n = 83, 31%), cardiologists (n = 126, 45%) or primary care physicians (n = 
39, 14%). 22  Providers may be reluctant to initiate discussions with patients about ICD 
management at the end of life, fearing these conversations may contribute to patient distress. 
However, the Pedersen group (2013) 25 found that the majority of their participants believed 
discussions would not increase anxiety in themselves (82%) or their families (68%) and that their 
wish for worthy death at end of life was independently associated with favorable attitude toward 
deactivation (or 2.14, 95% CI 1.49 to 3.06; p<0.0001).  
Conclusion 
The studies reviewed offer a more global insight into the knowledge, attitudes and desires 
of patients with ICDs with regards to end of life decision making. It is likely that patients have 
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insufficient knowledge regarding these issues. For patients receiving ICDs, informed consent as 
well as end of life planning should be considered an ongoing process beginning at the initiation 
of therapy and continuing through the disease process. Myths regarding the ethics of end of life 
decision making coupled with unrealistic expectations of these devices to prevent all causes of 
death persist. Patients without full understanding of these issues may be robbed of the 
opportunity to make informed choices in line with their values or ideas of life quality or a “good” 
death.  
Although the potential for recall bias is high within several of these retrospective studies 
which utilize participant interviews, the results do speak to the larger issues of informed consent 
prior to initiation of therapy, and the frequency with which patients are encouraged to make their 
desires for end of life through advanced directives, particularly directives which address 
management of ICDs as applicable. The generalizability of the studies reviewed is one 
limitation. Several studies in this review had relatively low sample sizes and did not routinely 
include patients who were at the end of life.  Additionally the largest sample of ICD recipients 
studied was from Sweden 24, which may limit applicability to populations in other parts of the 
world. 
The Heart Rhythm Society 14 and the European Heart Rhythm Society 9 recommend 
evidence based interventions promote advanced directive discussions including ICD specific 
directives as standard practice. One quality improvement initiative implanted in a university-
affiliated non-for-profit hospice was able to increase the proportion of hospice patients who died 
with a deactivated device by 27% through the implementation of ICD specific policies and 
procedures, by making device and manufacturer information more readily accessible, making 
deactivation magnets universally available, creating an ICD specific care plan, and improving 
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clinician and new-hire education. 28 Although this intervention shows promise for improving 
quality of death, time can vary significantly between ICD implementation and end of life. The 
consistent follow up and monitoring of all patients with ICDs during the treatment period 1 
presents numerous opportunities to provide adequate information to patients regarding these 
issues and this course of action is recommended by both the Heart Rhythm Society 14 and the 
European Heart Rhythm Society. 9 Patient-provider communication and clinical interventions 
can be enhanced in order to provide patients ample time to make informed decisions regarding 
their devices and therapy at the end of life. 
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Table 1  
Summary of Included Studies 
Author(s) (Year), 
Level of Evidence  
Design/Method  Purpose Sample/Setting Variables of 
Interest 
Findings  Significance  
Fluur et al (2013), 
level of evidence 
VI 
Grounded theory 
Interview 
Patient 
perspectives on end 
of life decisions at 
time decision for 
ICD intervention. 
30 participants 
from two ICD 
referral centers 
in Ontario. (24 
accepted ICD; 6 
declined ICD). 
Quality versus 
quantity of life. 
Preferred mode of 
death. 
Technical realities 
of ICD. 
Participant focus on avoidance 
of sudden cardiac death; the 
potential for death due to other 
causes not considered by most 
participants.  
End of life issues 
may not be 
discussed fully prior 
to ICD intervention. 
Strachan et al 
(2011), level of 
evidence VI 
Phenomenological 
Interview 
ICD recipients 
experiences with 
ICD, battery 
replacement and 
end of life issues. 
37 patients with 
ICDs for ≥6 
months and not 
in palliative 
stage of terminal 
illness from 5 
Swedish 
hospitals. 
Being a part of an 
uncertain illness 
trajectory. 
Standing at a 
crossroads. 
Progressing from 
one phase to 
another. 
 
Predominant positive attitudes 
towards ICD replacement; 
unrealistic attitudes regarding 
ICD to extend life. 
 
Minority of participants said 
they would make end of life 
decisions in advance of need or 
physical decline; few had 
advanced directives in place 
addressing the ICD. 
 
Patients may have a 
poor understanding 
of disease trajectory.  
Need exists to 
discuss end of life 
issues and promote 
ICD specific 
advanced directives 
with patients who 
have ICDs. 
Stromberg et al  (In 
press) level of 
evidence IV 
Cross-sectional 
correlational 
Written survey 
Describe 
knowledge of ICD 
therapy at end of 
life among ICD 
recipients; explore 
patient-related 
factors associated 
with poor 
insufficient ICD at 
end of life 
knowledge. 
3,067 ICD 
recipients 
recruited from 
the Swedish ICD 
and Pacemaker 
Registry 
Knowledge in 
relation to end of 
life issues 
Symptoms of 
anxiety and 
depression 
Quality of life 
Demographic and 
clinical variables 
29% with insufficient 
knowledge. Men more likely to 
have sufficient knowledge than 
women (72%, 65%; p<0.001) 
 
Age <65 years more likely than 
age ≥65 years to have sufficient 
knowledge (84%, 65%; 
p<0.001). 
 
Sufficient knowledge more 
likely if previously discussed 
Large cross 
sectional study in a 
national cohort. 
Population subsets 
at highest risk 
include women, 
older patients, less 
educated, or with 
symptoms of 
anxiety/depression. 
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with physician battery 
replacement (n = 1,250; 76% vs 
68%; p<0.001); deactivation 
(n=420; 76% vs 71%; 
p<0.001); illness trajectory 
(n=1,080; 78% vs 67%; 
p<0.001). 
 
28% (n=796) who believe 
deactivation is the same as 
euthanasia were more likely to 
be older (68±11 vs 65±12; 
p<0.001), female (31% vs 26%; 
p<0.001), lower education 
(42% ≤9 years vs 58% 
education >9 years; p<0.001); 
low quality of life score (0.793 
vs 0.828; p<0.001), with 
symptoms of depression (36% 
vs 26%; p<0.001) and anxiety 
(33% vs 25%: p<0.001) 
Herman et al 
(2013), level of 
evidence IV 
Cross-sectional 
correlational 
 
Written survey 
Understand patient 
opinions, attitudes, 
wishes and 
understanding of 
ICDs at end of life. 
112 participants 
with ICDs from 
an outpatient 
clinic in the 
Czech Republic. 
Opinions, 
attitudes, wishes 
and understanding 
of ICDs at end of 
life (13 item 
questionnaire) 
 
Number of prior 
shocks. 
 
Diagnosis of 
depression. 
 
Indication for 
ICD. 
 
Settings of ICD 
and length of 
therapy. 
45.9% (n=50) had not thought 
about ICD deactivation at end 
of life; 7.3% (n=8) had 
discussed ICD at end of life 
with their physician. 
 
No difference in questions 
between those with 
biventricular or non-
biventricular devices. 
 
No significant difference 
between patients with ICD for 
primary or secondary 
prevention. 
 
28% (n=31) patients had 
received a shock and were more 
likely to be hospitalized (1.21 
40.1% indicated a 
desire to be better 
informed, however 
only 7.3% of 
participants reported 
discussing ICD at 
end of life with their 
providers.  
 
25.7% indicated a 
refusal to discuss 
deactivation at end 
of life. 
 
Highlights the 
importance of 
shared decision 
making with regards 
to information 
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vs 0.79 hospitalizations, 
p<0.05). Of these, 8 (7.3%) had 
received inappropriate shock. 
 
Patients who “felt safer” were 
less likely to consider 
deactivation (r=-.245, p<0.05); 
felt sufficiently informed 
(r=0.2444, p<0.05); and had 
discusses deactivation (r=0.3, 
p<0.05). 
 
Shocked patients indicated 
adverse psychological 
consequences, felt they were 
insufficiently informed (r=-
0.368, p<0.05). Patients who 
live alone more likely to 
deactivate at end of life (r= -
0.21, p =0.025). Those who 
considered deactivation 
indicated they would make the 
decision without help (r=0.238,  
p<0.05) .   
  
sharing. However 
patients may be 
more receptive to 
these discussions if 
better informed. 
Pedersen et al 
(2013), level of 
evidence IV 
Cross-sectional 
correlational 
 
Written survey 
Examine patient 
knowledge and 
wishes for ICD at 
end of life 
information. 
Examine 
prevalence and 
correlations of 
positive attitudes 
towards 
deactivation at end 
of life. 
294 patients 
identified from a 
medical center in 
the Netherlands. 
 
Three groups: de 
novo implanted, 
moderate 
experience and 
considerable 
experience. 
Attitudes towards 
deactivation. 
 
Knowledge about 
deactivation. 
 
Demographic and 
clinical 
characteristics. 
 
Anxiety, 
depression and 
type-D 
personality. 
31% did not know ICD 
deactivation was possible. 
 
95% of participants believed 
ICD patients should be 
informed of the possibility of 
deactivation. 
 
62% believed patients should 
be informed orally and in 
writing. 
 
Participants believed 
discussions should occur before 
ICD therapy (49%), when life 
Trends for response 
for or against 
deactivation were 
seen with anxiety. 
 
Most patients do not 
anticipate increased 
anxiety in 
themselves related 
to end of life 
discussions. 
 
Many patients may 
be unaware that 
ICDs can be 
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expectancy is decreased (55%), 
before battery replacement 
(17%), and during dying 
process (26%).  
 
Participants believed 
discussions would not increase 
anxiety in themselves (82%) or 
their families (68%). 
 
246 participants (84%) could 
make a choice for or against 
deactivation. Patients less likely 
to choose included recent ICD 
(21%), moderate experience 
(16%) than those with 
considerable experience (10%) 
(n.s.). Of the 246, 195 favored 
deactivation.  
 
Wish for high quality of death 
independently associated with 
favorable attitude toward 
deactivation (or 2.14, 95% CI 
1.49 to 3.06; p<0.0001). 
 
deactivated at end of 
life.  
Kirkpatrick et al 
(2012), level of 
evidence IV 
Cross-sectional 
correlational 
 
Telephone survey 
Not stated 278 patients with 
ICDs extracted 
from a 
cardiovascular 
implantable 
electronic device 
clinic in 
Pennsylvania. 
Number of 
patients with 
ICDs have 
advanced 
directives that 
explicitly address 
the ICD  
 
Patient 
preferences for 
ICD handling 
particularly at end 
of life and in a 
hospice setting. 
103 (38%) of participants had 
been shocked (mean number of 
shocks 4.69); 80 (30%) were 
being followed by a palliative 
care physician; 56 (20%) had a 
cancer diagnosis. 
 
71 (26%) had a living will; 7 
(3%) had a healthcare power of 
attorney; 62 (22%) had both. 
Having an advanced directive 
was significantly associated 
with age (mean age 65 vs 57 
years). No other associated 
Patients desire 
discussions 
regarding end of life 
decision making and 
may prefer this 
information from 
their cardiologists or 
electrophysiologists. 
 25 
 
 
Belief that 
deactivation is the 
equivalent of 
physician assisted 
suicide. 
 
Perspectives on 
advanced 
directives for 
ICD. 
 
Physician 
preference for 
ICD handling.  
 
characteristics were noted. 
Only 3 (2%) participants had an 
advanced directive which 
specifically addressed their 
ICD. 
 
Most (n = 267, 96%) had never 
discussed ICD at end of life 
with physician. 
 
Most (n = 238, 86%) had not 
considered ICD in the event of 
serious illness. Of those who 
had, 30 (82%) had never 
discussed with a medical 
practitioner. 
 
11% (n = 28) stated would keep 
ICD on at end of life; 110 
(42%) were unsure. 26% 
(n=71) considered deactivation 
synonymous with physician 
assisted suicide, 8% (n=23) 
were unsure (trended 
downward in 2010). 
 
264 (95%) believed patients 
should have the chance to 
complete an ICD specific 
advanced directive. Most 
believed advanced directives 
should be initiated at follow up 
visit (n = 95, 34%), at end of 
life (n = 110, 40%) versus at 
implantation (n = 44, 16%) 
Tajouri, et al 
(2012), level of 
evidence IV 
Cross-sectional 
correlational 
 
Retrospective 
chart review 
Determine 
advanced directive 
prevalence among 
ICD recipients as 
well as the 
420 patients who 
had ICD 
implanted at the 
Mayo Clinic in 
Minnesota. 
Patients with 
advanced 
directive 
 
Patients with advanced 
directives were older at time of 
implantation (69 years vs 60, 
p<0.001), white (97% vs 90, 
p<0.02), and lived in Olmstead 
Patients often 
include general 
information 
regarding “life-
sustaining” 
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frequency with 
which advanced 
directives address 
ICD management 
at end of life. 
 
Group 1: ICD 
present (n = 127) 
 
Group 2: ICD 
absent (n = 293) 
Characteristics of 
the advanced 
directive 
County (local), Minnesota 
(14% vs 5%, p = 0.004). 
 
Patient with advanced directive 
likely to have renal 
insufficiency (40% vs 26%, p = 
0.005), COPD (p<0.02), cancer 
(p=0.02) and dementia 
(p=0.03). 
 
Differences between patients 
with ICD for primary or 
secondary prevention with and 
without advanced directive 
were not significant. 
 
Of 44 patients who died, ICD 
was deactivated in 7 (16%). 
advanced directive did not 
increase likelihood of 
deactivation. 
 
Of the patients with an 
advanced directive the majority 
were completed 12 months 
prior to implantation (83, 65%), 
the fewest completed after 
implantation (10, 8%) 
 
Only 2 advanced directives 
mentioned ICD or instructions 
for end of life. 
 
treatments in their 
advanced directive. 
Further education is 
need to clarify exact 
goals of care. 
 
 
Habal, et al (2011), 
level of evidence 
IV 
Cross-sectional 
correlational 
 
Prospective, semi-
structured 
interviews 
Determine HF 
patients’ 
awareness, 
understanding and 
utilization of 
advanced 
directives. 
41 participants 
from an 
ambulatory heart 
function clinic in 
Ontario. 
Demographics. 
 
Awareness of 
advanced 
directives 
31 (76%) did not know what 
advanced directives were. 
 
Of 19 patients with an ICD, 
only 2 (11%) reported 
discussing ICD deactivation 
with a physician. 
Patients require 
additional 
opportunities for 
education in order to 
make the most 
informed decisions. 
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Knowledge of 
resuscitation 
options 
 
Current 
resuscitation 
preference 
 
 
After patients educated on 
natural course of HF 9 (47%) 
stated they would like 
deactivation of defibrillator if 
their condition became worse; 5 
(26%) would not want it 
deactivated; 3 (16%) were 
unsure; 2 (11%) did not answer.  
 
Raphael et al 
(2011), level of 
evidence IV 
Cross-sectional 
correlational 
Semi-structured 
interview 
Describe patient 
understanding of 
consent for ICD 
intervention. 
Determine attitudes 
towards future 
deactivation. 
54 patients from 
a tertiary heart 
failure referral 
center in Boston. 
Group 1: (N=29) 
ICD but no 
shocks 
Group 2: (N=25) 
ICD for 6 
months and at 
least one shock 
Recollection of 
consent 
Timing of 
deactivation 
discussions 
Appropriate 
situations for 
device 
deactivation 
Option of variable 
switch-off device. 
85% recall discussing benefits 
at time of consent, less than 
half recall discussing risks or 
side effects. 
  
3% remember being informed 
the ICD could be deactivated at 
time of consent, 38% report 
becoming aware of potential for 
ICD deactivation later. 
 
24% of never shocked group 
did not want to discuss end of 
life. 
 
84% believed ICD deactivation 
should be discussed with 
provider; 52% believed these 
conversation should occur 
before ICD intervention. 
 
Discussions 
regarding 
deactivation should 
take place prior to 
initiation of ICD 
therapy, and 
reviewed after any 
shock therapy. 
Levels of evidence: Melnyk and Fineout-Overholt29: 
I. Evidence obtained from a systematic review or meta-analysis of all relevant randomized controlled trials 
II. Evidence obtained from at least one randomized controlled trial 
III. Evidence obtained from well-designed controlled trials without randomization 
IV. Evidence obtained from well-designed case control and cohort studies 
V. Evidence obtained from systematic reviews of descriptive and qualitative studies 
VI. Evidence from a single descriptive or qualitative study 
VII. Evidence from opinion of authorities and/or reports of expert committees 
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Figure 1. Study selection scheme 
 
 
 
Potentially relevant citations 
identified from PubMed 
(n = 133) 
 
Excluded as not relevant to search 
qualifiers, non-English language or 
>5 years  
(n = 108) 
 
Manuscripts excluded  
(n = 16) 
Provider attitudes: 4 
Expert recommendations: 3 
Consensus statements: 2 
Not specific to patient 
attitudes/knowledge about ICDs: 7 
 
 
Manuscripts included  
(n = 9) 
Qualitative studies: 2 
Non-experimental cohort studies: 7 
 
 
Included full text articles with 
potential relevance written in English 
within the last five years (n = 25) 
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Abstract 
Background: Prevalence of constipation in home hospice patients has been estimated between 
22% and 90%, with higher prevalence indicated when patients are self-reporting symptoms. The 
Centers for Medicare and Medicaid Services are adjusting reimbursements for hospice services 
based on the subjective experiences of symptom management among patients and their 
caregivers. The purpose of this paper is to describe the process of a nurse led practice 
improvement project to implement an evidence-based standing order set for constipation 
management in a home hospice setting utilizing patient experience data as an evaluative 
component. Methods: The steps of the Iowa Model for Evidence Based Practice Change were 
utilized for this practice implementation project. Hospice CAHPS Survey data was monitored as 
a proxy for intervention effectiveness. Results: Quarterly tracking and analysis of patient 
experience data regarding constipation management provided ongoing and reflexive feedback 
which was able to shape targeted interventions to improve outcomes. Discussion: As hospice 
nurses begin to appraise and adapt the evidence for constipation management, such data can 
prove useful in monitoring impact and adjusting practice accordingly to optimize outcomes. 
Conclusion: The roles of nursing in shared governance committees, quality assurance and 
performance improvement are complementary in the implementation of evidence based practice 
changes and monitoring effectiveness. 
 
Key words: Quality assurance; performance improvement; CAHPS; constipation. 
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Adoption of an Evidence-Based Bowel Protocol for Standing Orders in a Home Hospice 
Utilizing Patient Experience Data as an Evaluative Component 
Home hospice organizations are instrumental in promoting patient centered care to 
patients and families at the end of life. A fundamental aspect of quality hospice care is support of 
patients and families through expert pain and symptom management. One study estimated 92% 
of home hospice patients received an opioid during the last two months of their life 1. The role of 
opioids in the development of constipation is well established and development of constipation is 
further complicated by functional decline and disease progression. The reported prevalence of 
constipation in palliative care populations varies with estimates between 22% and 90%2-4. One 
study of patients admitted to specialized Palliative Care units in Sweden found the prevalence of 
constipation varied depending on the definition used. A 7% prevalence of constipation was 
observed when using a frequency-based definition versus a prevalence of 43% when constipation 
was patient-reported. 
The subjective experiences of patients and families is fast becoming a key component of 
health care reimbursement. The Centers for Medicare and Medicaid (CMS) has led this shift with 
their Value Based Purchasing Program, or “pay for performance” which utilizes weighted scores 
for process and patient experience to determine reimbursement for hospitals. Similarly CMS has 
responded to the mandate set forth from the Affordable Care Act of 2010 requiring hospice 
programs submit quality data via the Hospice Quality Reporting Program5. The Hospice Quality 
Reporting Program supports the Consumer Assessment of Healthcare Providers and Systems 
(CAHPS) Hospice Survey to gauge the experience and satisfaction of hospice patients through 
their identified informal caregivers6.  There are several eligibility requirements for the hospice 
CAHPS survey. The decedent must be at least 18 years of age and their death must have 
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occurred at least 48 hours following their last hospice admission date. There must be a primary 
caregiver on record in which to mail the survey and the caregiver has not previously declined to 
be contacted. The caregiver of record must also reside within the U. S. or a U. S. Territory. All 
surveys are administered by a third party CAHPS Hospice Survey vendor approved by the 
Centers for Medicare and Medicaid and contracted directly from the participating hospice. 
Caregivers for decedents of all payer sources and across all settings of hospice care (inpatient, 
home, assisted living, nursing home) are eligible for participation7.  
Conflicting and inconclusive evidence for the treatment of constipation among patients at 
or nearing the end of life complicates best practice adoption and implementation. In any setting, 
constipation is best treated through a patient centered approach which takes patients’ 
expectations into consideration as well as their perceptions of symptom burden8.  Shared 
governance councils are ideal vehicles for advancement of evidence based practice changes 
within institutions 9. Improvements in professional engagement have been demonstrated by 
evaluations of shared governance structures revealing that nurses feel their voices are 
strengthened, that they are able to take ownership of the practice environment and that 
interprofessional collaborations are promoted to solve complex clinical problems 10. The purpose 
of this paper is to describe the process of a nurse led practice improvement project to implement 
an evidence-based standing order set for constipation management in a home hospice setting 
utilizing patient experience data as an evaluative component. 
Methods  
The Iowa Model of Evidence-Based Practice  
 The Iowa Model of Evidence-Based Practice as described by Titler and colleagues (2001) 
provides the framework for identification of a relevant topic for clinical inquiry, team formation, 
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appraisal and synthesis of the relevant best evidence, application of changes, evaluation and 
dissemination. Step one involves identifying a problem-focused or knowledge-focused trigger 
where an evidence based practice change may be needed. Second, the determination must be 
made if the identified problem is indeed an organizational priority. Third, a team should be 
assembled to develop the evidence based practice change. Fourth, the team must develop the 
research question and then collect any relevant evidence in the literature.  Fifth, the team must 
critique and synthesize the research for use in practice. Sixth, after the team determines the 
amount and quality of the available evidence is adequate an implementation plan is developed. 
Seventh, once the practice is determined adaptable, the team may decide to make further 
refinements or, if the change is appropriate for adoption it may be instituted. Eighth, the practice 
change is then monitored through observation and analysis of structure, process and outcome 
data. Finally, the results are disseminated 11,12. 
Population and Setting 
This evidence based practice improvement project occurred at a community-based, 
hospital affiliated non-profit hospice organization in northern Kentucky between October 2015 
and October 2016. The program serves patients in seven counties and cares for them in their 
private residences, assisted living communities and long term care facilities. The program 
maintains an average daily census of approximately 160 patients. Registered nurses responsible 
for triage of phone calls after regular business hours began to notice a trend of increased patient 
and family complaints of constipation with fecal impaction. Although standing orders for 
management of constipation were available for registered nurses to initiate when clinically 
indicated, they had not been updated to reflect changes in practice knowledge. These problem 
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focused triggers initiated the evidence-based practice change cycle, prompting a review of 
current practices, processes and protocols.  
Data Collection and Analysis 
At the next point in the Iowa Model, a decision must be made to determine if the problem 
is an organizational priority. During monthly meetings of the of the home hospice unit based 
design council the group worked collaboratively to determine this. In order to tease out possible 
sources of the problem, a data tracking form was shared with after-hours hospice staff in order to 
monitor patient and family reported incidence of impaction. Several communications were sent 
to all nursing staff asking for participation in gathering this data. Thirteen incidents of impaction 
were noted in an eight-week period. The most frequently cited comment reported was patient 
medication non-adherence. During the same time period, the quality assurance and performance 
improvement nurses began pilot implementation of quality measure data collection for the 
Hospice CAHPS Survey. The unit based design council and the quality assurance and 
performance improvement nurses identified two constipation related measures on the Hospice 
CAHPS Survey to use as external benchmarks for measuring the success of planned practice 
changes. The following questions were used: 1) While your family member was in hospice care, 
did your family member ever have trouble with constipation; and 2) How often did your family 
member get the help he or she needed for trouble with constipation. Responses were measured 
on a four point Likert-type scale (“never”, “sometimes”, “usually”, “always”) with “always” 
identified as the target response.  
Process Implementation 
The unit based design team working with the quality assurance performance 
improvement nurses became the core team for the practice change. The team sought out and 
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received the support of the nurse managers, hospice medical director and the collaborating 
hospice pharmacist. All members of the team made themselves available to review and approve 
any proposed changes. The unit based design team was then able to develop the research 
question in order to collect and appraise the relevant evidence (Table 1). 
The next step of the Iowa Model describes the development of an implementation plan. 
After the evidence was synthesized and critiqued by the team, the standing order set for bowel 
management was evaluated for consistency with current practice recommendations, evidence, 
cost effectiveness and population need (Figure 1). Several changes were made to the order set 
including the increasing the prn dose range for Senokot-S to reflect a maximum therapeutic dose 
of one to four tabs twice daily; the addition of a Bisacodyl 10mg rectal suppository daily as 
needed; and the addition of time-based parameters for the initiation of rectal interventions. 
Recognizing the importance of continued staff education to coincide with the implementation of 
the new standing order set, further refinements were made to the intervention. First, hospice-
specific, evidence-based clinical reference material in the form of a computer based learning 
module was made available to all nursing staff. Second, clinical information systems were 
reviewed for their utility and ease of use. Specifically, the team reviewed the current electronic 
medical record flowsheet for gastrointestinal assessment and collaborated to evaluate the 
accessibility of the standing order set in the patient chart.  
Results 
Outcomes evaluation of the practice change includes monitoring and analysis of structure 
and process data including environment, staff, cost and impact on the patient and family. The key 
outcome measure determined by the workgroup became quarterly monitoring of the CAHPS 
Hospice Survey.  In the first quarter of Hospice CAHPS reporting this hospice met the national 
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benchmark for total number of “always” responses to the questions “Patient received help for 
constipation.” These results revealed additional opportunities for further improvement, including 
improving perception of constipation management for hospice patients in nursing homes. To 
follow up, the team began discussions with the unit team leader, a key member of the team 
dedicated to education and practice improvement of the electronic medical record. The team 
began to develop methods to extract additional evaluative reporting data include incidence of 
rectal interventions and documentation of primary caregiver bowel management teaching. 
Finally, dissemination of information including instruction and rationale for bowel regimen and 
patient experience data tracking changes was shared during unit based design council meetings, 
nursing team meetings. Additionally, the quality assurance and performance improvement nurses 
maintained public bulletin boards reporting patient experience data.  
Discussion 
Bowel regimens are necessary as constipation can produce significant physical symptoms 
for the terminally ill patient including pain, nausea and vomiting, rectal tears and bleeding, 
bloating or abdominal distention, a sense of fullness and a sense of urgency 13. When untreated, 
constipation can lead to increasingly severe complications including anorexia, dehydration, 
abdominal pain, urinary retention or in severe cases, total bowel obstruction. Psychological 
distress related to constipation and its symptoms can lead to poor quality of life for both the 
patient and caregivers manifesting as anxiety, depression or agitation 3,14. Additionally, patients 
may assign meaning to their worsening constipation and identify it as a sign of worsening 
disease or health status 14.  Planned interventions must take into consideration involvement of the 
patient and caregiver to promote a patient centered approach which aligns all treatments with 
patient goals, preferences and values. Many causes of constipation may not be easily reversible 
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in the hospice patient as the progressive worsening of a life limiting disease often leads to a 
compounding effect of causative factors 15.  
Successful symptom management is a core service of any hospice program. The 
importance of successful management of symptoms, particularly constipation is illustrated in the 
patient experience data collection currently being implemented by the Centers for Medicare and 
Medicaid Services. Although public reporting of the Hospice CAHPS Survey is not estimated to 
begin until 2018, failure to comply with CMS submission guidelines for quality data results in a 
2 point penalty for reimbursements, in effect creating a “pay for reporting” reimbursement 
system5. Hospices which are early adopters of this quality reporting program have the 
opportunity to strengthen programs which support the best possible patient outcomes while 
simultaneously maximizing reimbursement potential for their programs. 
Conclusion 
Clavelle and colleagues (2016) have re-conceptualized shared governance as professional 
governance and define it as “the accountability, professional obligation, collateral relationships 
and decision-making of a professional, foundational to autonomous practice and achievement of 
exemplary empirical outcomes.” (p. 310). In this example shared governance is a model 
supportive of professional nursing practice which operates interdependently of management. 16.  
Shared governance structures empower nurses to take ownership of practice patterns, improve 
nursing care quality, maintain professional competence and act as stewards of nursing 
knowledge through its creation and dissemination 12,16.   
Evidence based nursing care lies at the intersection of best evidence, expert opinion and 
the stated values, goals and preferences of patients and families. Interventions aimed at 
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management of constipation by the hospice and palliative care nurse must continuously be 
evaluated through the lens of patient and caregiver perceptions of care to achieve patient 
centered care. Continued innovation is needed in the realms of research and performance 
improvement to arrive at improved interventions and prevention strategies for the management 
of constipation in populations nearing or at the end of life. Patient experience surveys create an 
essential foundation to an emerging paradigm in healthcare where quality care with the patient at 
the nucleus is incentivized. Hospice programs with robust frontline leadership teams in 
collaboration with quality assurance and performance improvement teams will be best prepared 
for the transition to increased transparency via public reporting programs. Perhaps more 
importantly hospice programs with this framework in place will increase their organizational 
agility by quickly identifying related patterns in patient and family reported experiences and 
clinical outcomes and responding accordingly. 
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Table 1 
Summary of Evidence 
Author(s), 
Year 
Design/Model Purpose Sample/Setting Variables of Interest Significance 
Abernathy et al. 
(2003)17 
Review Summary of palliative 
management of GI 
symptoms in advanced 
cancer patients. 
NA Nausea/Vomiting 
Constipation 
Diarrhea 
Constipation rates for 
terminally ill cancer 
patients between 50-
87% 
Andrews & 
Morgan 
(2013)18 
Expert 
recommendation 
Improved assessment 
and complex symptom 
management can 
enhance patient self-
management and 
sense of control. 
NA Assessment; contributing factors; 
psychological impact; physiological 
impact; treatment options; lifestyle 
changes 
NA 
Candy et al. 
(2015)15 
Meta-analysis of 
seven RCTs involving 
616 participants 
To evaluate the 
effectiveness of 
laxatives versus 
methylnatrexone for 
prophylaxis or 
treatment of 
constipation 
616 patients with 
advanced cancer 
or other chronic 
life limiting 
illnesses. 
Laxation, methylnaltrexone, lactulose, 
senna, codanthramer, misrakasneham, 
magnesium hydroxide with liquid 
paraffin. 
No clear superior 
treatment for 
constipation 
management can be 
established. 
Clark & 
Currow (2013)4 
Systematic review of 
20 articles examining 
treatment of 
constipation in a 
hospice/palliative care 
setting. 
To systematically 
examine the definition 
and primary outcome 
measures used to 
study constipation 
among 
hospice/palliative care 
populations. 
20 articles 
examining 
treatment of 
constipation in a 
hospice/palliative 
care setting.  
Primary outcomes varied and included: 
laxation, bowel function, defecation-free 
intervals of 72 hours, time to laxation, 
number and types of laxatives, 
constipation severity, average number of 
bowel actions in the preceding three 
weeks. 
There is an unmet need 
for a validated tool that 
can be used to evaluate 
constipation 
consistently in the 
literature. 
Hawley & 
Byeon (2008)19 
Nonrandomized, non-
blinded sequential 
cohort study 
To compare the 
effectiveness of 
sennosides  
60 Canadian 
patients 
hospitalized >5 
days with a 
cancer diagnosis: 
30 docusate plus 
sennosides 
protocol 
Sennosides only protocol produced 
significantly more BM than sennosides 
with docusate protocol (p<0.05). 
Sennosides only group admitted for 
symptom control and supportive care had 
more BMs >50% of days compared to 
sennosides plus docusate (62.5% vs 
32%). More patients receiving sennosides 
Sennosides only were 
more effective at 
inducing laxation. No 
difference in incidence 
of bowel cramps was 
noted between groups. 
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(control) versus 
30 sennosides 
only protocol 
(intervention) 
plus doscusate received supplement of 
lactulose, suppository or enema (57% vs 
40%); cramping reported equally in both 
groups; diarrhea more frequent in 
sennosides only group (27% vs 13%) 
Librach et al. 
(2010)20 
Expert 
recommendation 
To define best 
practices in 
constipation 
management for 
patients with advanced 
progressive illness. 
NA Best practices include assessment, 
physical examination, non-
pharmacological interventions (toileting, 
mobility, increasing oral intake if 
appropriate) and pharmacological 
interventions. 
While its role is limited 
to treatment of opioid 
induced constipation, 
methylnaltrexone is 
recommended to 
improve sleep. 
Larkin et al. 
(2008)21 
Expert 
recommendation 
To define best 
practices in 
constipation 
management for 
patients enrolled in 
palliative care. 
NA Treatment of constipation focused on 
addressing the underlying cause. The use 
of a stimulant laxative combined with a 
softening agent is recommended.  
Data describing safety 
and efficacy of 
laxatives in a palliative 
care population are 
limited. 
Tarumi, 
Wilson, Szafran 
& Spooner 
(2013)22 
RCT To assess efficacy of 
docusate in hospice 
patients. 
74 patients from 
three Canadian 
inpatient hospice 
units. (35 
docusate group, 
39 placebo 
group). 
No significant difference between the 
sennosides and docusate group vs 
sennosides alone. 
Addition of docusate to 
bowel regimen should 
carefully consider 
continued assessment 
findings, overall 
medication burden and 
patient preference. 
Thomas et al. 
(2008)23 
RCT To assess safety and 
efficacy of 
subcutaneous 
methylnaltrexone in 
palliative care patients 
with opioid induced 
constipation. 
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OLD ORDERS NEW ORDERS 
• Increase fluids and exercise as tolerated 
• Senokot-S tablets oral 1-2 tablets BID or 
Miralax 17gm in 8oz fluid daily PRN 
• Administer Fleets, Soap Suds or Milk and 
Molasses enema PRN 
 
• Increase fluids and exercise as tolerated 
 
• Senokot-S tablets 1-4 tablets BID OR 
Miralax 17grams in 8oz fluid daily PRN  
 
• Bisacodyl 10mg rectal suppository daily 
prn (no BM x3 days or PRN) 
 
• Administer fleets, soap suds or mineral oil 
or milk and molasses enema PRN (no BM 
>3 days or PRN) 
 
Figure 1. Comparison between old and new standing orders 
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Abstract 
Background: Clear communication of the purpose and benefits of palliative care can reduce 
barriers to acceptance of such services for patients and families. The purpose of this practice 
improvement project was to assess and improve knowledge and perceptions of palliative care 
among patients with a diagnosis of heart failure and cancer in the acute setting using a video 
enhanced education intervention. Methods: This practice improvement project took place at a 
555 bed teaching hospital. 18 patients referred to an inpatient palliative care consult service in 
the acute care setting with a diagnosis of either heart failure or cancer participated. Result: 
Paired sample t-tests were conducted to examine the effectiveness of the intervention in patients’ 
scores assessing level of palliative care awareness (Table 2). There was a significant positive 
difference in the scores for level of palliative care awareness before (M = 2.56, SD = 1.25) and 
after (M = 3.72, SD = 1.179) a five-minute video describing palliative care; t(17) = 3.82 p = 
.001. Discussion: Video interventions delivered at the point of care in the acute setting may be 
an effective tool for improving knowledge and perceptions of palliative care among patient with 
diagnoses of heart failure or cancer. Conclusion: The benefits of video education may be 
enhanced when delivered with the addition of face to face interaction by a member of the 
healthcare team versus a video self-administered by the patient. Further evaluation is needed. 
 
Key Words: palliative care; patient education; video enhanced education  
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A Practice Improvement Project to Improve Knowledge and Perceptions of Palliative 
Care among Patients with Heart Failure and Cancer in the Acute Setting Using Video Enhanced 
Education 
The World Health Organization1 defines palliative care as “…an approach that improves 
the quality of life of patients and their families facing the problem associated with life-
threatening illness, through the prevention and relief of suffering by means of early identification 
and impeccable assessment and treatment of pain and other problems - physical, psychosocial, 
and spiritual.” Palliative care is a medical specialty that can be accessed for any individual living 
with a serious illness and is appropriate for persons at any stage of a serious illness at any age. 
Members of the palliative care team work alongside members of the patient’s primary care team 
to provide an extra layer of support and assist in alleviating the symptoms, pain and stress of a 
serious illness. Members of the palliative care team can help clarify patients’ and families’ goals 
of care and assist in the alignment of prescribed medical treatments with these desires. Models 
for palliative care delivery exist in both inpatient and outpatient settings.2  
Palliative care continues to be a growing medical specialty due to multiple factors. In 
particular, the impact on national health and overall disease burden among aging baby boomers 
nation-wide is estimated to result in the rapid growth of persons aged 65 and older between 2010 
and 2050. By the year 2050 the projected number of Americans aged 65 and older is 88.5 million 
– effectively doubling the current size of this population.3 As the population continues to age the 
incidence of persons living with a serious illness is estimated to increase correspondingly. 
According to the Centers for Disease Control and Prevention the top three causes of death in the 
United States in 2013 were heart disease (611,105), cancer (585,881) and chronic lower 
respiratory diseases (149,205)4. Currently an estimated 80% of older adults are living with a 
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chronic condition and an estimated 50% are living with at least two chronic conditions further 
contributing to their influx into the acute and ambulatory settings.4  
At the end of a serious illness trajectory the medical and nursing care that is delivered 
becomes increasingly complex. Hospice care, which currently requires a physician certification 
that an individual has six months or less to live, is a philosophy of care delivery which falls 
under the umbrella of palliative care. Unfortunately “just in time” hospice utilization has been 
ineffective in reducing resource utilization, with duration of hospice enrollment averaging 3 days 
and often preceded by multiple transitions in care during the last months of life.5 One proposed 
solution to the escalation of resource utilization at the end of a serious illness trajectory is to 
increase the frequency of advanced care planning conversations with patients and families prior 
to condition deterioration. These discussions are facilitated by expert palliative care clinicians 
can elicit patient preferences for treatment at the end of life so that the care patients receive is in 
line with their values, beliefs and informed decisions. Effective advanced care planning 
conversations decrease resource utilization and aggregate health care costs 6-9 and have 
demonstrated positive effects on caregiver-reported quality of death.8 In addition to enhancing 
patient centered care through expertly managed advanced care planning, palliative care has been 
associated with reduced patient suffering, improved symptom recognition, improved pain 
management, improved quality of life and improved survival outcomes for oncology patients 
receiving palliative care concurrent with curative treatments.10-14  
Problem 
A 2011 study commissioned by the Center to Advance Palliative Care created a snapshot of 
public awareness, attitudes and perceptions of palliative care15 to provide a framework to 
improve communication regarding the benefits and future direction of this specialty with 
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consumers and policymakers. Data were collected from a national survey of 800 adults age 18 or 
older to assess current palliative care knowledge. When asked, “How knowledgeable, if at all, 
are you about palliative care?” the overwhelming majority of respondents reported they were 
“not at all knowledgeable” about palliative care. After information was provided to patients 
regarding palliative care using clear, understandable language, an increase in individuals’ 
willingness to incorporate palliative care into their medical care was observed. Among persons 
who reported no prior knowledge about palliative care and were given the opportunity to gain an 
increased understanding about it, 92% reported they would be likely to utilize palliative care 
services if they or their families were confronted with a serious illness. Additionally, 92% of 
these individuals believed that they should have access to palliative care in the hospital setting.15 
During transitions in care, particularly as individuals move between outpatient to inpatient 
settings, patient education becomes critical and should be a continuous intervention.16 It is likely 
that inpatients admitted for treatment related to their serious illness are unaware that palliative 
care services are available to them, and that this issue is further complicated by the fact that 
healthcare providers may use the terms “palliative care” and “end of life care” or “hospice” 
interchangeably. Educational interventions targeted at improving knowledge and understanding 
of palliative care should include standardized messages which have been tested in order to best 
dispel myths and eliminate the confusion which exists for patients as they learn to differentiate 
between hospice and palliative care.15  
Review of the Literature 
Currently, multiple national and specialty-specific guidelines recommend early integration of 
palliative care for patients with serious illness. For patients with advanced heart failure the 
American Heart Association recommends involvement of the palliative care team prior to a 
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patient reaching refractory end stage heart failure.17 For patients with advanced metastatic cancer 
diagnoses, the early integration of palliative care is supported by the National Comprehensive 
Cancer Network which cites uncontrolled symptoms, moderate to severe diagnosis or treatment 
related distress, serious comorbidity, a life expectancy of one year or less, patient or family 
concerns regarding any aspect of the disease course or related decision-making or the request of 
patients or family members as indications for a palliative care referral.18  Similarly the American 
Society of Clinical Oncology issued a provisional clinical opinion that palliative care should be 
considered for any patient with metastatic cancer and/or a high symptom burden after a phase III 
randomized controlled trial found increased survival benefit, improvement in symptoms, 
improved quality of life, increased patient satisfaction and reduced caregiver burden when 
palliative care was combined with standard anti-cancer therapy.14,19 
Confusion, myths and fear persist among the public and health care providers alike regarding 
how to best define palliative care. A review of the literature utilizing “palliative care” as a search 
term returns a greater number of studies written about end of life or hospice issues than papers 
examining the role of palliative care in a role supportive to active or curative treatments.20  The 
Institute of Medicine’s 2014 report, “Dying in America: Improving Quality and Honoring 
Individual Preferences Near the End of Life” identified key recommendations for improving 
quality and patient-centered outcomes for individuals approaching the end of life including the 
delivery of person-centered, family-oriented care and improved clinician-patient 
communication.21 Communicating the key messages and goals of palliative care effectively 
reduce barriers to patient participation in palliative care programs and is an essential step to 
improving outcomes. 
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Patients are able to make informed decisions reflecting their values, goals and beliefs when 
they have accurate information about palliative care. One qualitative study explored public 
awareness and perceptions of palliative care.22 When asked, patients in the study expressed the 
importance of dispelling myths surrounding palliative care and that public education through TV 
advertisements, posters and leaflets, and inviting cancer survivors to act as “ambassadors” to 
educate others were valued educational strategies.22 Patients and families desire accurate 
information which enables them to make educated decisions regarding their planned medical 
care. This finding further supports the findings of the Center to Advance Palliative Care public 
opinion study cited earlier.15 
To date, the seminal Study to Understand Prognoses and Preferences for Outcomes and 
Risks of Treatments (SUPPORT)23 is the largest study examining outcomes related to enhanced 
communication between seriously ill patients and health care providers. No significant 
improvements were noted in key outcome variables such as incidence and timing of written DNR 
orders, physician knowledge of resuscitation preferences, ICU length of stay, and incidence of 
mechanical ventilation or reduced hospital resource utilization as a result of a patient-physician 
communication intervention. Interventions which address patient-physician communication 
alone may not be enough to impact patient-centered outcomes for the seriously ill.  
  With the exception of the Center to Advance Palliative Care commissioned survey, 
there are few contemporary studies exploring educational interventions to enhance palliative care 
knowledge and awareness for patients. Additionally, a few recent studies have explored 
opportunities during an acute hospitalization to provide education, which distinguishes the 
difference between palliative care and hospice or end of life services. A video enhanced 
educational intervention provides a unique opportunity to clarify the principles of palliative care 
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for patients in the acute care setting and can be delivered by any member of the interdisciplinary 
team. The purpose of this practice improvement project was to improve knowledge and 
perceptions of palliative care among patients with a diagnosis of heart failure and cancer in the 
acute setting using a video enhanced education intervention.  
Methods 
Design, Sample and Setting 
The setting for this project was a 555 bed teaching hospital in Cincinnati, Ohio. The 
palliative care service at this facility is composed of advanced practice nurses, registered nurses, 
social workers, physicians and chaplains with expertise in palliative care. Consultations are 
triggered on admission for all patients with a diagnoses of advanced metastatic cancer or 
advanced (New York Heart Association Class III/IV) heart failure by the attending physician. 
Activities of the palliative care service include advanced symptom assessment and management, 
care coordination among multiple specialties, management and support of the spiritual, cultural 
and emotional aspects of care, advanced care planning and expert communication of patient and 
family goals of care to the entire healthcare team.   
For the purposes of this practice improvement project, the target population was 
composed of acutely ill inpatients with diagnoses of either advanced hematologic or solid tumor 
cancer or advanced heart failure referred to the palliative care service.  A portion of the 
accessible population reported prior exposure to palliative care services at this facility from a 
previous admission.  As such, this subset of patients serves as a distinct comparison group with 
patients with patients having no previous palliative care experience. Patients considered for 
inclusion were adults 18 years of age or older, English speaking, inpatients referred to the 
palliative care service with a heart failure or cancer diagnosis, able and willing to provide 
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consent and participate voluntarily and able to respond verbally to the survey questions 
administered. Permission was obtained from The Christ Hospital Institutional Review Board and 
the University of Kentucky Institutional Review Board. Decisional capacity was determined by 
successful completion of a six-item dichotomous (yes/no) screening tool prior to patients 
providing consent to participate.  Data collection occurred between April 1 and June 31, 2016. A 
convenience sample of 18 patients was identified within the described population who met 
inclusion criteria for recruitment into this practice improvement project.   
Video Enhanced Education 
A brief video was created by myself in collaboration with the palliative care team which 
describes the concept and philosophy of palliative care as well as summarizes the palliative care 
service available specifically at facility. All media utilized to create the video was obtained with 
permission under a royalty free license. Stock audio media was provided by 
TuneLight/Pond5.com and stock video footage was provided by Eldelik, Monkey Business 
Images, Wavebreakmedia Ltd and Dreamstime.com. Recording of the narrative, editing and 
production took place at the University of Kentucky Media Depot. The video was reviewed and 
approved by the interdisciplinary palliative care team. The acute care hospital retains proprietary 
rights to the video. The video script (Appendix A) was derived from “Brochure Guidelines” by 
the Center to Advance Palliative Care and incorporates messaging guidance from public opinion 
research.15 A video education format was favored for several reasons. Video-enhanced education 
is a cost effective method of delivering information to inpatient populations. A video can be 
easily delivered to the bedside on-demand and can be provided by the primary nurse, who may 
be the first to identify patients who could benefit from palliative care.   
Evaluation 
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Descriptive demographic data collected includes patient age, gender, race, level of 
education, employment status and marital status. Health related demographic data includes 
diagnosis (cardiac or oncologic), previous contact or interaction with the palliative care consult 
team, hospital visit type (planned or acute) and palliative performance scale score. Palliative 
performance scale scores were extracted from the patient electronic medical record. 
Level of awareness of palliative care was assessed utilizing a five-point Likert-type scale 
whereby patients were asked to report “not any knowledge”, “only a little knowledge”, “unsure”, 
“some knowledge” or “a lot of knowledge”. All patients were then asked to respond to ten 
additional statements from a survey assessing palliative care knowledge. This survey reflected 
the messaging recommendations by the Center to Advance Palliative Care utilizing a ten-item, 
five-point Likert-type survey (“strongly agree”, “disagree”, “unsure”, “agree”, “strongly agree”). 
The survey asked patients to rank the following items regarding inpatient palliative care: 
Improves quality of life for patients; improves quality of life for families; provides 
compassionate care; can help me manage my pain; can help me manage symptoms other than 
pain such as shortness of breath or nausea; can be given along my regular (life-prolonging) 
treatments for my condition; is made up of a team of doctors, nurses, social workers, chaplains 
and pharmacists; can assist me with any spiritual or emotional concerns I have; provides an extra 
layer of support for me and my family; will communicate with my primary doctor about my 
condition. The survey and level of palliative care knowledge patient reported assessment were 
administered at baseline and immediately after the video intervention to evaluate affective 
learning. 
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Procedure 
Patients identified as eligible for inclusion were approached by the principle investigator. 
The study’s purpose and protocol were explained in detail to the patient. Informed consent was 
obtained and documented by the principle investigator. Upon giving their informed consent, 
patients were given a content evaluation survey to assess their prior knowledge of palliative care. 
Patients were then asked to view the educational video describing palliative care and the content 
evaluation survey was repeated.  All surveys were administered verbally by the principal 
investigator. Data were managed using REDCap (Research Electronic Data Capture) electronic 
data capture tools hosted at The University of Kentucky College of Nursing.24 REDCap is a 
secure, web-based application designed to support data capture for research studies, providing 1) 
an intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and 
export procedures; 3) automated export procedures for seamless data downloads to common 
statistical packages; and 4) procedures for importing data from external sources24. 
Data Management and Analysis 
Descriptive statistics were used to summarize the demographic and clinical 
characteristics of the patients. Paired t-tests were used to assess changes in palliative care 
knowledge between baseline and immediate post intervention scores. Change scores were 
calculated as the difference between the post-intervention and baseline scores for palliative care 
knowledge. All data analysis was conducted using SPSS version 20 and an alpha level of 0.5 was 
used throughout.  
Results 
Among 18 patients 10 (55.6%) were female and 14 (77.8%) were Caucasian. More 
patients were admitted with a primary diagnosis of cancer (n=12; 66.7%) than heart failure (n=6; 
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33.3%). A greater number of patients in the sample reported their admission as the first contact 
with the palliative care team (n=12; 66.7%) than those reporting contact during a prior admission 
(n=6; 33.3%) (Table 1).   
Paired sample t-tests were conducted to examine the effectiveness of the intervention in 
patients’ scores assessing level of palliative care awareness (Table 2). There was a positive 
difference in the scores for level of palliative care awareness pre (M = 2.56, SD = 1.25) and post 
(M = 3.72, SD = 1.179) video intervention; t(17) = 3.82 p = .001. Positive differences were also 
noted for the following survey items before and after the video education intervention 
respectively: “Palliative care improves quality of life for patients” (M = 3.78, SD = .73; M = 
4.22, SD = .73; t(17) = 3.69 p = .002); “Palliative care improves quality of life for families” (M = 
3.89, SD = .76; M = 4.22, SD = .65; t(17) = 2.92 p = .010); “Palliative care can help me manage 
symptoms other than pain such as shortness of breath or nausea” (M = 3.50, SD = .79; M = 4.11, 
SD = .90; t(17) = 3.72 p = .002); “Palliative care can be given along with my regular (life-
prolonging) treatments for my condition” (M = 3.89, SD = .68; M = 4.39, SD = .50; t(17) = 3.43 
p = .003); “Palliative provides an extra layer of support for me and my family” (M = 3.83, SD = 
.86; M = 4.28, SD = .75; t(17) = 3.06 p = .007); “The palliative care will communicate with my 
primary doctor about my condition” (M = 4.00, SD = .69; M = 4.50, SD = .51; t(17) = 4.12 p = 
.001); Overall, there was a statistically significant increase in total palliative care knowledge 
scores pre video intervention (M=41.56, SD=6.64) and post video intervention (M=46.61, SD= 
6.25); t(17) = 4.83, p < .0005. (Table 2). The mean increase in total scores was 5.06 with a 95% 
confidence interval ranging from 7.26 to 2.85. The eta squared statistic (0.58) indicating a large 
effect size. 
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Discussion 
Prior research supports our findings of the efficacy of video based interventions on 
increasing knowledge related to disease. Frosch and colleagues compared a group of men aged  
≥50 years of age who received education from a video about the risks and benefits of PSA 
screening and found a video-based decision aid (n=112) was significantly more effective than 
information presented via the internet (n=114)  (t (221) = 4.07, P < .001), 25 reflecting results 
similar to those found by these authors. This could be due to two reasons. First, the video 
interventions in the Frosch group’s study and these authors’ intervention have the advantage of 
being available at the point of care and were initiated in the health care setting where patients 
were likely to be present to their current health concerns. Second, Frosch and colleagues suggest 
that patients may prefer health information from reputable and trustworthy sources such as 
directly from the healthcare provider in the acute care setting. A video delivered to palliative care 
patients during an inpatient hospital stay may influence patient perceptions of the trustworthiness 
of educational intervention however further evaluation is needed. 
In another study conducted by Moonaghi and colleagues, attitudes related to diet and 
fluid intake among 75 hemodialysis patients were assessed at four data points after face-to-face 
and video educational interventions.26 The authors found no significant differences and equal 
efficacy between face to face and video methods of education at baseline, two and four weeks 
post intervention (face to face: respectively; p < .001, p < .001, p <.001; video: p < .001, p < 
.001, p = .001). It is important to note that when these authors delivered the palliative care video 
education, encounter times with patients averaged about an hour. Often, the act of collecting 
demographic data (asking patients’ if their admission was acute versus planned for example) 
elicited historical narratives including details about recent treatments, complications, frustrations 
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and hopes. It is possible that receiving the video intervention at the bedside with the opportunity 
to ask questions and have a member of the healthcare team bear witness to the patient’s 
experience is preferable to the delivery of a video that a patient self-administers or views 
independently. Further research regarding the benefits of interventions which combine elements 
of face to face and video enhanced teaching in palliative care populations is needed. 
Generalizability of the results obtained from this practice improvement project to a larger 
population is limited by the small sample size. In addition, a larger sample could have 
illuminated differences in change scores associated with demographic elements of the sample. 
However, by including patients with both heart failure and cancer this sample is representative of 
those patients in the acute care setting who are most likely to utilize palliative care services. The 
video and the survey used to assess palliative care knowledge were developed to ensure 
consistency with tested language recommended by the Center to Advance Palliative Care. 
Although consensus recommendations exist for inpatient palliative care programs, variation 
among hospitals and regions exists between programs with regards to program maturity, staffing 
and clarity of mission and vision. While the video includes material that is specific to the 
palliative care program available at this facility, it does contain content based on national 
recommendations and is reflective of the best evidence available for practice change in this 
population.  
Measures for health related quality of life and patients’ perceived involvement in care 
were intended to be part of the final analysis, however these were incorrectly administered thus 
invalidating the data. Inclusion of these measures could have provided further insight into 
possible associations between any changes in palliative care knowledge and perceived 
involvement in care or quality of life, particularly if these evaluations could have occurred in low 
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up period of patients were discharged. Conducting research with palliative care populations 
poses unique challenges. Patients eligible for palliative care consultation in a hospital setting are 
by definition higher acuity with the potential for rapid changes in functional status and a limited 
prognosis due to their advanced illness, limiting the feasibility of long-term follow-up. 
Conclusion 
The video as proposed is designed to be available to all inpatient nursing staff as an 
educational aid for palliative care appropriate patients within the project setting. The video will 
be made available in the patient education television channel, SkyLite. Utilizing this technology 
allows the electronic medical record to be updated when the video is shown to a patient to 
document the patient has received this education. This practice improvement project is 
significant because it addresses common barriers in palliative care communication to patients 
who are hospitalized in an acute care setting. Scripted communication fulfils the goals of 
palliative care education to patients, families, and non-specialty members of the healthcare team 
while simultaneously strengthening the messages presented by specialist team members. 
Effective communication is an essential clinical tool in the palliative care professional’s arsenal. 
As the palliative care specialty continues to define mission and vision and evolve its scientific 
basis for practice a consistent presentation and clear message is needed to provide a clear picture 
of what palliative care is, and what it is not to enable patients to make the difficult decisions 
needed to receive the medical care they desire through the serious illness continuum.  
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Table 1  
Demographic Characteristics of Participant Sample 
Variables Frequency (n=18) Percentage 
Age   
< 65 11 61.1% 
≥ 65 7 38.9% 
Gender   
Female 10 55.6% 
Male 8 44.4% 
Race   
Black or African American 4 22.2% 
White or Caucasian 14 77.8% 
Education   
Some high school 3 16.7% 
Some college 12 66.7% 
Graduate degree 3 16.7% 
 Employment status   
Employed 2 11.1% 
Unemployed 0 - 
Retired 8 44.4% 
Disabled 8 44.4% 
Relationship status   
Married/partnered 12 66.7% 
Single/living alone 6 33.3% 
Primary diagnosis   
Cancer 12 66.7% 
Heart Failure 6 33.3% 
Hospital visit type   
Planned 5 27.8% 
Acute 13 72.2% 
Previous palliative care 
contact 
  
Yes 6 33.3% 
No 12 66.7% 
Self –reported health status   
Excellent 0 - 
Very Good 3 16.7% 
Good 6 33.3% 
Fair 6 33.3% 
Poor 3 16.7% 
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Table 2 
Repeated Measures Data from Pre and Post Video Intervention Survey Scores 
 Mean  
(Pre and Post 
Video) 
Std. Deviation 
(Pre and Post 
Video) 
t* p (< .05) 
Level of palliative care 
awareness 
     2.56 
     3.72  
1.25 
1.18 
3.823 .001 
Quality patient care 3.78 
4.22  
.73 
.73 
3.688 .002 
Quality for families 3.89 
4.22  
.76 
.65 
2.915 .010 
Compassion 4.22 
4.39  
.73 
.78 
.825 .421 
Pain management 3.72 
4.17  
.83 
.86 
1.917 .072 
Symptoms managed 3.50 
4.11  
.79 
.90 
3.716 .002 
Regular treatment 3.89 
4.39 
.68 
.50 
3.431 .003 
Team 4.11 
4.39 
.68 
.61 
1.567 .135 
Spiritual 4.00 
4.22 
.84 
1.00 
1.719 .104 
Support 3.83 
4.28 
.86 
.75 
3.063 .007 
Communication 4.00 
4.50 
.69 
.51 
4.123 .001 
Total Score 41.56 
46.61 
6.64 
6.25 
4.832 <.0005 
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Conclusion 
Professor of psychiatry and medicine at Harvard Medical School Susan Block states, 
“Our main procedure in palliative care is difficult communication1 Indeed communicating 
difficult information, whether related to the impacts of a life limiting illness, or urging nurses 
and colleagues from other health care disciplines that changes in practice can achieve better 
outcomes. The palliative care CNS is uniquely poised to impact change and improve patient care 
outcomes in the palliative care specialty. The findings of this practice inquiry project illuminate 
the potential impact of the DNP prepared CNS working to advance the palliative care specialty 
through translation and implementation of practice changes within all three CNS spheres of 
influence by acknowledging the interrelatedness of each aspect of the healthcare system.  
 The integrative review summarizing patient attitudes and knowledge about Implantable 
Cardioverter Defibrillator deactivation creates a path for practice change within the 
organizations/systems sphere of influence. Through critical appraisal and synthesis of the current 
barriers to patient knowledge, the CNS can initiate the interdisciplinary dialogue needed to create 
sustainable changes in practice that facilitate optimal palliative care delivery at the primary level 
among generalist members of the healthcare team, as well at the secondary level, among 
specialist palliative care providers. The second manuscript focusing on the nurse and nursing 
sphere of influence describes the integration of best evidence into practice to optimize bowel 
management for hospice patients. This is accomplished through the application of the Iowa 
Model for evidence based practice integration and monitored utilizing national benchmarks to 
evaluate effectiveness and to continue to identify new areas for improvement. Finally, the 
implementation of a video enhanced education intervention illustrates the impact of the CNS at 
the patient/family sphere of influence. Through the translation of existing research and expert 
recommendations, a bedside intervention for seriously ill patients creates the opportunity to 
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improve understanding of key palliative care concepts, thereby creating access to care by 
reducing barriers created by misinformation and fear. The three spheres of influence model of 
CNS practice acknowledges the interrelatedness of each aspect of the healthcare system. This 
ultimately impacts current practices at the micro and macro levels and will be essential in driving 
new and meaningful changes in a fragmented healthcare system.  
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Appendix A 
Palliative Care Script 
If you are seriously ill, you should know that The Christ Hospital has a special program to help you during your 
hospitalization. The Christ Hospital’s Palliative Care Service provides comprehensive and compassionate care 
focused on relief of suffering and improvement of quality of life for patients and families coping with serious illness 
while they are in the hospital. Palliative care is specialized medical care for people with serious illnesses. This type 
of care focuses on relieving the symptoms, pain and stresses of a serious illness—whatever the diagnosis. 
The goal of palliative care is to improve quality of life for both the patient and the family. Palliative care is provided 
by a team of doctors, nurses and other specialists working in partnership with a patient, their medical specialists and 
their family to provide an extra layer of support. Palliative care is appropriate at any age and at any stage in a serious 
illness, and can be provided together with curative treatment. 
Who is on the palliative care team? 
The team is made up of physicians, nurses, chaplains, social workers and pharmacists experienced in palliative care. 
They will work alongside the patient’s other doctors and healthcare providers.   
  
What happens during a palliative care consultation? 
A doctor and/or nurse who specializes in palliative care will review the patient’s records and speak with the patient’s 
other doctors. Members of the team will meet with the patient and/or his or her loved ones to assess patient and 
family needs. When appropriate, they will arrange a family care conference to discuss the patient’s medical issues, 
options and goals of care. The team will document findings in the medical record and make recommendations for 
treatment when necessary. 
 
What types of treatment can be provided? 
The palliative care team will provide care based on the unique needs of each patient. Patient and family involvement 
is encouraged to foster a better understanding of the illness and goals of care. 
• The palliative care team can address symptoms such as pain, trouble sleeping, shortness of breath, nausea, 
weakness and other conditions causing discomfort.  
• The team can coordinate care when several specialists are treating varying aspects of the patient’s illness.  
• The team can assist with making daily physical activities easier and offer exercise and nutrition planning.  
• Specialists in spiritual care and social work can address the spiritual, cultural and emotional aspects of care.  
• Team members will support patients and families to ensure their goals of care are clearly understood and aligned 
with the medical treatments offered, especially if the patient becomes unable to communicate his or her wishes.  
• The team will assist patients, their families and the hospital staff to make plans for care upon discharge from the 
hospital.  
Is palliative care just another name for hospice? 
Palliative care is often confused with hospice – which is care focused on comfort when life-prolonging treatments 
are no longer helpful. Palliative care is different. Even patients who are expected to fully recover from a serious 
illness may benefit from palliative care services, which can be provided alongside full life-prolonging treatments.   
How are palliative care consultations requested? 
A palliative care consultation requires a doctor’s order. If you believe that you or your loved one would benefit from 
palliative care, you may ask your doctor to request a consultation. You may also receive more information by calling 
the palliative care team at 513-585-4157. 
Palliative care reflects The Christ Hospital’s commitment to patient- and family-centered care, which focuses on 
treating patients and families with dignity and respect, information sharing, participation and collaboration. Through 
this service, we hope to empower patients and families to make healthcare decisions with peace of mind.  
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Appendix B 
Level of Palliative Care Awareness Survey 
1. Please rate your level of awareness of palliative care: 
(1) Not any knowledge 
(2) Only a little knowledge 
(3) Unsure 
(4) Some knowledge 
(5) A lot of knowledge 
 
Please answer the following questions regarding palliative care: 
2. Palliative care improves quality of life for patients 
(1) Strongly disagree 
(2) Disagree 
(3) Unsure 
(4) Agree 
(5) Strongly agree 
 
3. Palliative care improves quality of life for families 
(1) Strongly disagree 
(2) Disagree 
(3) Unsure 
(4) Agree 
(5) Strongly agree 
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4. Palliative care provides compassionate care 
(1) Strongly disagree 
(2) Disagree 
(3) Unsure 
(4) Agree 
(5) Strongly agree 
 
5. Palliative care can help me manage my pain 
(1) Strongly disagree 
(2) Disagree 
(3) Unsure 
(4) Agree 
(5) Strongly agree 
 
6. Palliative care can help me manage symptoms other than pain such as shortness of breath or 
nausea 
(1) Strongly disagree 
(2) Disagree 
(3) Unsure 
(4) Agree 
(5) Strongly agree 
 
7. Palliative care can be given along my regular (life-prolonging) treatments for my condition 
(1) Strongly disagree 
(2) Disagree 
(3) Unsure 
(4) Agree 
(5) Strongly agree 
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8. Palliative care is made up of a team of doctors, nurses, social workers, chaplains and 
pharmacists 
(1) Strongly disagree 
(2) Disagree 
(3) Unsure 
(4) Agree 
(5) Strongly agree 
 
9. Palliative care can assist me with any spiritual or emotional concerns I have 
(1) Strongly disagree 
(2) Disagree 
(3) Unsure 
(4) Agree 
(5) Strongly agree 
 
10. Palliative care provides an extra layer of support for me and my family 
(1) Strongly disagree 
(2) Disagree 
(3) Unsure 
(4) Agree 
(5) Strongly agree 
 
11. The palliative care team will communicate with my primary doctor about my condition 
(1) Strongly disagree 
(2) Disagree 
(3) Unsure 
(4) Agree 
(5) Strongly agree 
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Appendix C 
Center to Advance Palliative Care (2011) Key Messages 
Key Messages Definition of Palliative Care 
Key messages are essential tools for any kind 
of communication with your audience. They 
bridge what your audience already knows 
with where you are trying to lead them. Your 
key messages will change depending on the 
topic or question you’re going to address. 
Most of the time you will want to use no more 
than three key messages. 
The top messages below reinforce for the 
public the goals of palliative care. They 
address the topic/question “What is palliative 
care? “ 
• Palliative care helps to provide the 
best possible quality of life for a 
patient and their family. 
• Palliative care helps patients and 
families manage the pain, symptoms, 
and stress of serious illness. 
• Palliative care is a partnership of 
patient, medical specialists, and 
family. 
• Palliative care is appropriate at any 
age and at any stage in a serious 
illness and can be provided along with 
curative treatment. 
• Palliative care provides an extra layer 
of support for families and patients 
with serious illness. 
The following definition should be used when 
defining or describing palliative care for 
consumers: 
Palliative care is specialized medical care for 
people with serious illnesses. This type of 
care is focused on providing patients with 
relief from the symptoms, pain, and stress of a 
serious illness—whatever the diagnosis. 
The goal is to improve quality of life for both 
the patient and the family. Palliative care is 
provided by a team of doctors, nurses, and 
other specialists who work with a patient's 
other doctors to provide an extra layer of 
support. Palliative care is appropriate at any 
age and at any stage in a serious illness, and 
can be provided together with curative 
treatment. 
 
 
 
 
